NPPA fixes retail prices of 44 formulations
National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 44 formulations including those indicated for the treatment of hypertension, depression, high blood sugar levels caused by type 2 diabetes, etc under Drugs (Prices Control) Order, 2013. The price fixation is based on the decision of 115th Authority meeting dated 31.07.2023.The drugs whose prices have been fixed...
National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 44 formulations including those indicated for the treatment of hypertension, depression, high blood sugar levels caused by type 2 diabetes, etc under Drugs (Prices Control) Order, 2013.
The price fixation is based on the decision of 115th Authority meeting dated 31.07.2023.
The drugs whose prices have been fixed include MSN Labs and Sanofi India's Sitagliptin Phosphate and Metformin Hydrochloride Tablets, Akum Drugs & Pharma and Mankind Pharma's Levetiracetam, Sodium Chloride Infusion, Akums Drugs & Pharma and Abbott Healthcare's Aceclofeanc, Paracetamol & Serratiopeptidase Tablet, Akums Drugs & Pharma and Cipla's Chlorthalidone, Amlodipine & Telmisartan Tablets.
For more details, check out the link given below:
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd